| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.003 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.005 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.34 | 0.006 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.007 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |